PCSK9 (Bococizumab Biosimilar) antibody

Catalog No. ABIN7490979

The Humanized Monoclonal anti-PCSK9 (Bococizumab Biosimilar) antibody has been validated for FACS. It is suitable to detect PCSK9 (Bococizumab Biosimilar) in samples from Human.

Quick Overview for PCSK9 (Bococizumab Biosimilar) antibody (ABIN7490979)

Target: PCSK9 (Bococizumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This PCSK9 (Bococizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-PCSK9 (Bococizumab Biosimilar) Antibody

Purpose: Anti-PCSK9 (Bococizumab biosimilar) mAb

Characteristics: PF-04950615, RN-316, RN316

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG2

Application Details

Application Notes: Flow Cyt  1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for PCSK9 (Bococizumab Biosimilar)

Target: PCSK9 (Bococizumab Biosimilar)

Target Type: Biosimilar

Background: FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9

UniProt: Q8NBP7